Legal & General Group’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8K Sell
3,352
-6,266
-65% -$27.6K ﹤0.01% 3249
2026
Q1
$34.7K Sell
9,618
-526
-5% -$1.82K ﹤0.01% 2777
2025
Q4
$34.6K Hold
10,144
﹤0.01% 2824
2025
Q3
$68.9K Hold
10,144
﹤0.01% 2675
2025
Q2
$138K Buy
10,144
+6,614
+187% +$62.5K ﹤0.01% 2617
2025
Q1
$19.2K Hold
3,530
﹤0.01% 2957
2024
Q4
$17.5K Hold
3,530
﹤0.01% 3073
2024
Q3
$18.5K Hold
3,530
﹤0.01% 3082
2024
Q2
$24.3K Buy
+3,530
New +$32.3K ﹤0.01% 2952

Other funds holding LFMD

Legal & General Group's LFMD Position: Q2 2026 in Review

Legal & General Group reduced its LifeMD (LFMD) stake by 65% in Q2 2026, selling an estimated $27.6K and leaving 3,352 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3249.

Legal & General Group first reported a position in LFMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $138K in Q2 2025. 115 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Legal & General Group held 3,352 shares of LifeMD worth $13.8K as of Q2 2026.
  • Legal & General Group sold 6,266 LifeMD shares in Q2 2026, an estimated $27.6K.
  • LifeMD made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3249 holding.
  • Legal & General Group first reported a position in LifeMD in Q2 2024 and has held it in 9 quarters since.
  • Legal & General Group's LifeMD position peaked at $138K in Q2 2025.
  • 115 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.